Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Robert K. Hickman.
Journal of Virological Methods | 1998
Robert K. Hickman; Ana Vallari; Alan M. Golden; Jennifer M. Lund; John Hackett; Cathy Brennan; Sushil G. Devare
Recombinant antigens and peptides were used to develop an HIV slot immunoblot assay to confirm and differentiate infection by HIV-1 group M, HIV-1 group O or HIV-2. Recombinant antigens from the gag, pol or env regions of HIV-1 and HIV-2, in addition to synthetic peptides from the immunodominant region (IDR) of transmembrane proteins gp41 (HIV-1) or gp36 (HIV-2), were blotted on nitrocellulose strips and used as a substitute for competitive Western blots. Evaluation of a large number of samples (N = 440) from various regions of the world, using the immunoblot, showed effective differentiation of HIV-1 group M, HIV-1 group O and HIV-2. The immunoblot identified correctly all (24/24) HIV-1 group O samples that were confirmed subsequently by PCR and sequence analysis. The immunoblot is a useful tool for identifying HIV-1 group O seropositive samples and has the potential to identify other serological HIV variants that may represent detection problems for HIV screening assays using HIV-1 group M subtype B reagents.
Journal of Acquired Immune Deficiency Syndromes | 1999
James W. Scheffel; Robert N. Ziemann; David J. Hawksworth; Joan D. Tyner; Robert K. Hickman; John Hackett
Monoclonal antibodies were developed to a recombinant HIV-I group O envelope protein derived from the isolate HAM112. These monoclonal antibodies were characterized for reactivity to a series of overlapping synthetic peptides (29-30 mers) covering gp120 C-terminal and gp41 ectodomain regions of the HIV-1 group O envelope protein. Most of these monoclonal antibodies reacted with peptides spanning sequences analogous to HIV-1 group M epitopes identified from studies in mice and humans. However, several of the antibodies that were nonreactive to individual peptides did react to a mixture of longer peptides from the N-terminal and C-terminal helical regions of the gp41 ectodomain. The monoclonal antibodies described in this study are valuable tools for characterization of antigenic differences between HIV-1 group O and group M viruses.
Archive | 1998
Anadruzela S. Vallari; John R. Hackett; Robert K. Hickman; Vincent A. Varitek; Elizabeth C. Necklaws; Alan M. Golden; Catherine A. Brennan; Sushil G. Devare
Archive | 1998
John R. Hackett; Julie Yamaguchi; Alan M. Golden; Catherine A. Brennan; Robert K. Hickman; Shushil G. Devare
AIDS Research and Human Retroviruses | 1997
Catherine A. Brennan; Julie Yamaguchi; Ana Vallari; Robert K. Hickman; Sushil G. Devare
Journal of Clinical Microbiology | 1998
Ana Vallari; Robert K. Hickman; John R. Hackett; Catherine A. Brennan; Vincent A. Varitek; Sushil G. Devare
BioTechniques | 2000
Martin A. Winkler; Robert K. Hickman; Alan M. Golden; Hoda Aboleneen
Archive | 1998
Anadruzela S. Vallari; John R. Hackett; Robert K. Hickman; Vincent A. Varitek; Elizabeth C. Necklaws; Alan M. Golden; Catherine A. Brennan; Sushil G. Devare
Archive | 2011
Catherine A. Brennan; Alan M. Golden; John R. Hackett; Robert K. Hickman; Julie Yamaguchi; アラン・エム・ゴールデン; キヤスリーン・エイ・ブレナン; ジユリー・ヤマグチ; ジヨン・アール・ハケツト,ジユニア; ロバート・ケイ・ヒツクマン
Archive | 2008
Catherine A. Brennan; Alan M. Golden; John R. Hackett; Robert K. Hickman; Julie Yamaguchi; アラン・エム・ゴールデン; キヤスリーン・エイ・ブレナン; ジユリー・ヤマグチ; ジヨン・アール・ハケツト,ジユニア; ロバート・ケイ・ヒツクマン